Related Experiment Video
Updated: Jun 27, 2025
06:24
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
297
Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond
Calogero Ciulla1, Claudio Luchini1,2
1Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy.
Expert Review of Molecular Diagnostics
|May 6, 2024
Summary
Pancreatic cancer shows significant molecular diversity. Targeting KRAS mutations and understanding specific molecular markers like SMAD4 and TP53 are crucial for improving patient survival and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Pancreatic cancer exhibits substantial histomolecular heterogeneity, with diverse genomic profiles across tumor subtypes.
- Understanding molecular drivers of aggressiveness is key to improving patient outcomes.
Purpose of the Study:
- To review essential molecular determinants of biological aggressiveness and poor prognosis in pancreatic cancer.
- To identify subgroups with unfavorable prognoses for targeted research efforts.
Main Methods:
- Expert-based narrative review of data from PubMed, SCOPUS, and Embase.
- Analysis of molecular alterations including KRAS mutations, transcriptome data, and specific biomarkers (SMAD4, TP53).
Main Results:
- KRAS mutations (>90% of tumors) present a major therapeutic challenge, often lacking actionable targets.
- Squamous phenotype correlates with poorer prognosis and reduced response to chemotherapy.
- Specific biomarkers like SMAD4 and TP53 are associated with dismal prognosis in certain pancreatic cancer subsets.
Conclusions:
- Targeting KRAS is a critical step for improving survival in pancreatic cancer.
- Identifying prognostically unfavorable subgroups guides research and precision oncology strategies.
Related Concept Videos
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K